
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Showing 1-25 of 931 citing articles:
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo, et al.
Nature Reviews Microbiology (2019) Vol. 18, Iss. 2, pp. 67-83
Open Access | Times Cited: 1975
Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo, et al.
Nature Reviews Microbiology (2019) Vol. 18, Iss. 2, pp. 67-83
Open Access | Times Cited: 1975
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1809
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1809
RNA editing with CRISPR-Cas13
David Cox, Jonathan S. Gootenberg, Omar O. Abudayyeh, et al.
Science (2017) Vol. 358, Iss. 6366, pp. 1019-1027
Open Access | Times Cited: 1538
David Cox, Jonathan S. Gootenberg, Omar O. Abudayyeh, et al.
Science (2017) Vol. 358, Iss. 6366, pp. 1019-1027
Open Access | Times Cited: 1538
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu, Shannon M. Miller, Maarten H. Geurts, et al.
Nature (2018) Vol. 556, Iss. 7699, pp. 57-63
Open Access | Times Cited: 1391
Johnny H. Hu, Shannon M. Miller, Maarten H. Geurts, et al.
Nature (2018) Vol. 556, Iss. 7699, pp. 57-63
Open Access | Times Cited: 1391
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees, David R. Liu
Nature Reviews Genetics (2018) Vol. 19, Iss. 12, pp. 770-788
Open Access | Times Cited: 1361
Holly A. Rees, David R. Liu
Nature Reviews Genetics (2018) Vol. 19, Iss. 12, pp. 770-788
Open Access | Times Cited: 1361
Diversity, classification and evolution of CRISPR-Cas systems
Eugene V. Koonin, Kira S. Makarova, Feng Zhang
Current Opinion in Microbiology (2017) Vol. 37, pp. 67-78
Open Access | Times Cited: 1285
Eugene V. Koonin, Kira S. Makarova, Feng Zhang
Current Opinion in Microbiology (2017) Vol. 37, pp. 67-78
Open Access | Times Cited: 1285
Gene therapy comes of age
Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, et al.
Science (2018) Vol. 359, Iss. 6372
Open Access | Times Cited: 1161
Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, et al.
Science (2018) Vol. 359, Iss. 6372
Open Access | Times Cited: 1161
The Biology of CRISPR-Cas: Backward and Forward
Frank Hille, Hagen Richter, Shi Pey Wong, et al.
Cell (2018) Vol. 172, Iss. 6, pp. 1239-1259
Open Access | Times Cited: 928
Frank Hille, Hagen Richter, Shi Pey Wong, et al.
Cell (2018) Vol. 172, Iss. 6, pp. 1239-1259
Open Access | Times Cited: 928
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski, Arnab Rudra, Lei Miao, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 710-728
Open Access | Times Cited: 903
Piotr S. Kowalski, Arnab Rudra, Lei Miao, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 710-728
Open Access | Times Cited: 903
Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity
Alexis C. Komor, Kevin T. Zhao, Michael S. Packer, et al.
Science Advances (2017) Vol. 3, Iss. 8
Open Access | Times Cited: 693
Alexis C. Komor, Kevin T. Zhao, Michael S. Packer, et al.
Science Advances (2017) Vol. 3, Iss. 8
Open Access | Times Cited: 693
Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
Benjamin P. Kleinstiver, Alexander A. Sousa, Russell T. Walton, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 3, pp. 276-282
Open Access | Times Cited: 585
Benjamin P. Kleinstiver, Alexander A. Sousa, Russell T. Walton, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 3, pp. 276-282
Open Access | Times Cited: 585
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek, Piotr S. Kowalski, Daniel G. Anderson
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 580
James C. Kaczmarek, Piotr S. Kowalski, Daniel G. Anderson
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 580
A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing
Beverly Mok, Marcos H. de Moraes, Jun Zeng, et al.
Nature (2020) Vol. 583, Iss. 7817, pp. 631-637
Open Access | Times Cited: 542
Beverly Mok, Marcos H. de Moraes, Jun Zeng, et al.
Nature (2020) Vol. 583, Iss. 7817, pp. 631-637
Open Access | Times Cited: 542
Engineered pegRNAs improve prime editing efficiency
James W. Nelson, Peyton B. Randolph, Simon P. Shen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 402-410
Open Access | Times Cited: 494
James W. Nelson, Peyton B. Randolph, Simon P. Shen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 402-410
Open Access | Times Cited: 494
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski, Peng Li, Warren J. Leonard
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 648-659
Closed Access | Times Cited: 490
Rosanne Spolski, Peng Li, Warren J. Leonard
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 648-659
Closed Access | Times Cited: 490
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Xue Gao, Yong Tao, Verónica Lamas, et al.
Nature (2017) Vol. 553, Iss. 7687, pp. 217-221
Open Access | Times Cited: 478
Xue Gao, Yong Tao, Verónica Lamas, et al.
Nature (2017) Vol. 553, Iss. 7687, pp. 217-221
Open Access | Times Cited: 478
Genetic Dissection of Neural Circuits: A Decade of Progress
Liqun Luo, Edward M. Callaway, Karel Svoboda
Neuron (2018) Vol. 98, Iss. 2, pp. 256-281
Open Access | Times Cited: 453
Liqun Luo, Edward M. Callaway, Karel Svoboda
Neuron (2018) Vol. 98, Iss. 2, pp. 256-281
Open Access | Times Cited: 453
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Mitsuo Kato, Rama Natarajan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 327-345
Open Access | Times Cited: 452
Mitsuo Kato, Rama Natarajan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 327-345
Open Access | Times Cited: 452
Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene
X. Shawn Liu, Hao Wu, Marine Krzisch, et al.
Cell (2018) Vol. 172, Iss. 5, pp. 979-992.e6
Open Access | Times Cited: 422
X. Shawn Liu, Hao Wu, Marine Krzisch, et al.
Cell (2018) Vol. 172, Iss. 5, pp. 979-992.e6
Open Access | Times Cited: 422
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation
Hsin‐Kai Liao, Fumiyuki Hatanaka, Toshikazu Araoka, et al.
Cell (2017) Vol. 171, Iss. 7, pp. 1495-1507.e15
Open Access | Times Cited: 404
Hsin‐Kai Liao, Fumiyuki Hatanaka, Toshikazu Araoka, et al.
Cell (2017) Vol. 171, Iss. 7, pp. 1495-1507.e15
Open Access | Times Cited: 404
Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery
Holly A. Rees, Alexis C. Komor, Wei-Hsi Yeh, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 389
Holly A. Rees, Alexis C. Komor, Wei-Hsi Yeh, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 389
Origins and evolution of CRISPR-Cas systems
Eugene V. Koonin, Kira S. Makarova
Philosophical Transactions of the Royal Society B Biological Sciences (2019) Vol. 374, Iss. 1772, pp. 20180087-20180087
Open Access | Times Cited: 388
Eugene V. Koonin, Kira S. Makarova
Philosophical Transactions of the Royal Society B Biological Sciences (2019) Vol. 374, Iss. 1772, pp. 20180087-20180087
Open Access | Times Cited: 388
Glycosylase base editors enable C-to-A and C-to-G base changes
Dongdong Zhao, Ju Li, Siwei Li, et al.
Nature Biotechnology (2020) Vol. 39, Iss. 1, pp. 35-40
Open Access | Times Cited: 387
Dongdong Zhao, Ju Li, Siwei Li, et al.
Nature Biotechnology (2020) Vol. 39, Iss. 1, pp. 35-40
Open Access | Times Cited: 387
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu, Jun Wang, Yulin Liu, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 13, pp. 1240-1247
Open Access | Times Cited: 384
Lei Xu, Jun Wang, Yulin Liu, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 13, pp. 1240-1247
Open Access | Times Cited: 384
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
Jordan L. Doman, Aditya Raguram, Gregory A. Newby, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 5, pp. 620-628
Open Access | Times Cited: 354
Jordan L. Doman, Aditya Raguram, Gregory A. Newby, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 5, pp. 620-628
Open Access | Times Cited: 354